Susceptibility of Human Immunodeficiency Virus Type 1 to the Maturation Inhibitor Bevirimat Is Modulated by Baseline Polymorphisms in Gag Spacer Peptide 1

In this study, we evaluated baseline susceptibility to bevirimat (BVM), the first in a new class of antiretroviral agents, maturation inhibitors. We evaluated susceptibility to BVM by complete gag genotypic and phenotypic testing of 20 patient-derived human immunodeficiency virus type 1 isolates and...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Van Baelen, Kurt, Salzwedel, Karl, Rondelez, Evelien, Van Eygen, Veerle, De Vos, Stephanie, Verheyen, Ann, Steegen, Kim, Verlinden, Yvan, Allaway, Graham P., Stuyver, Lieven J.
Formato: Artigo
Lenguaje:Inglês
Publicado: American Society for Microbiology (ASM) 2009
Materias:
Antiviral Agents
Acceso en línea:https://ncbi.nlm.nih.gov/pmc/articles/PMC2681549/
https://ncbi.nlm.nih.gov/pubmed/19223634
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1128/AAC.01650-08
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares